Festag, J. et al. Vector-mediated delivery of human MHC-I into hepatocytes enables investigation of TCR-redirected HBV-specific T cells in mice and macaque cell cultures. Hum. Gene Ther. 34, 1204-1218 (2023)
Dudaniec, K.* ; Westendorf, K.* ; Nößner, E. & Uckert, W.* Generation of Epstein-Barr virus antigen-specific T cell receptors recognizing immunodominant epitopes of LMP1, LMP2A, and EBNA3C for immunotherapy. Hum. Gene Ther. 32, 919-935 (2021)
Hazini, A.* et al. miR-375- and miR-1-regulated coxsackievirus B3 has no pancreas and heart toxicity but strong antitumor efficiency in colorectal carcinomas. Hum. Gene Ther. 32, 216-230 (2021)
Schreiber, S. et al. Characterization of MHC class II-restricted t-cell receptors for t-cell therapy of HBV infection. Hum. Gene Ther. 30, A10-A10 (2019)
Festag, M. et al. Evaluation of a fully human car for the treatment of hepatitis B virus infection in an immunocompetent mouse model. Hum. Gene Ther. 29, A4-A4 (2018)
Lorenz, F.K.* et al. Unbiased identification of T-cell receptors Targeting immunodominant peptide-MHC complexes for T-cell receptor immunotherapy. Hum. Gene Ther. 28, 1158-1168 (2017)
Wisskirchen, K. et al. Hepatitis B virus (HBV)-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV. Hum. Gene Ther. 28, A30-A30 (2017)
Geiger, S.* et al. Amelioration of lung function and pulmonary tissue regeneration after treatment with Alpha-1 antitrypsin (AAT)-expressing mesenchymal stem cells (MSCs) in a murine model of elastase-induced emphysema. Hum. Gene Ther. 27, A34-A34 (2016)
Conde, J.* et al. Designing gold nanoparticles for in vivo gene silencing as a new therapeutic tool. Hum. Gene Ther. 24, A24 (2013)
Morscher, S. et al. Imaging virus-mediated melanin production using Multispectral Optoacoustic Tomography (MSOT). Poster:  (2013)
Buchner, A.* et al. Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 21, 285-297 (2010)
Stocking, C.* et al. Cell and virus genetics at the roots of gene therapy, retrovirology, and hematopoietic stem cell biology: Wolfram Ostertag (1937-2010). Hum. Gene Ther. 21, 1501-1503 (2010)
Brill, T.H.* et al. Therapeutic vaccination with an Interleukon-2-Iinterferon-γ-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer - a phase I/II trial. Hum. Gene Ther. 20, 1-11 (2009)
Pinkenburg, O.* et al. Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth. Hum. Gene Ther. 20, 159-167 (2009)
Schwerdt, A.* et al. Hyperthermia-induced targeting of thermosensitive gene carriers to tumors. Hum. Gene Ther. 19, 1283-1292 (2008)
Thirion, C.* et al. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum. Gene Ther. 17, 193-205 (2006)
Engels, B.* et al. Redirecting Human T Lymphocytes toward Renal Cell Carcinoma Specificity by Retroviral Transfer of T Cell Receptor Genes. Hum. Gene Ther. 16, 799-810 (2005)
di Nicola, M.* et al. Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene : A Phase I Trial. Hum. Gene Ther. 14, 1347-1360 (2003)
Bauer, M. et al. Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease. Hum. Gene Ther. 11, 1529-1541 (2000)
Salmons, B. & Günzburg, W.H. Targeting of Retroviral Vectors for Gene Therapy. Hum. Gene Ther. 4, 129-141 (1993)
Salmons, B.* & Günzburg, W.H. Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4, 129-141 (1993)